Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Trade Show, Webcast

Sanderson Farms to Participate in BMO Capital Markets Farm to Market Virtual Conference


Sanderson Farms, Inc. (NASDAQ: SAFM) today announced that management will participate in the BMO Capital Markets 15th Annual Farm to Market Conference to be held May 13-14, 2020. Due to the COVID-19 pandemic, this conference will be held in a virtual format only.

The investor presentation by Joe F. Sanderson, Jr., chairman and chief executive officer, and Mike Cockrell, treasurer, chief financial officer & chief legal officer, will begin at approximately 3:20 p.m. Eastern Time on Wednesday, May 13, 2020, and will be available to investors via a live audio webcast. A link to the broadcast can be found at the investor relations section of the Company's website, www.sandersonfarms.com, and a replay will be available for 30 days.

Sanderson Farms, Inc. is engaged in the production, processing, marketing and distribution of fresh, frozen and minimally prepared chicken. Its shares trade on the NASDAQ Global Select Market under the symbol SAFM.


These press releases may also interest you

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...



News published on and distributed by: